Profile
Sector:
Consumer DefensiveIndustry:
Grocery StoresCountry:
United StatesIPO:
Website:
http://maisonsolutionsinc.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 20 Nov 2024 23:49:35 GMTDividend
Analysts recommendations
Institutional Ownership
MSS Latest News
MONTEREY PARK, CA / ACCESSWIRE / September 23, 2024 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the first quarter ended July 31, 2024. Management Commentary "We are pleased with our financial results for Q1 2025, as it marked the first full quarter with Lee Lee included under the Maison Solutions umbrella," said John Xu, President, Chairman and Chief Executive Officer of Maison Solutions.
- Confirmed partial responses (PRs) doubled to four since ASCO GI in MSS CRC patients without liver and peritoneal metastases for overall response rate (ORR) of 24% (4/17) with ADG126 10 mg/kg every three weeks (Q3W) in combination with pembrolizumab -
– IDMC recommendation to advance based on favorable safety profile observed in Phase 1a portion of trial – WALTHAM, Mass. , June 6, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it has advanced into the Phase 1b portion of its Phase 1/2 proof-of-concept trial of revumenib, the Company's highly selective, oral menin inhibitor, as a monotherapy in patients with relapsed or refractory (R/R) metastatic microsatellite stable (MSS) colorectal cancer (CRC).
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced a novel analysis from the Phase 1b trial of botensilimab in combination with balstilimab (BOT/BAL) in relapsed/refractory microsatellite stable colorectal cancer (r/r MSS CRC) with no active liver metastases (NLM) will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024. The.
Maison Solutions has filed proposed terms for a $12 million U.S. IPO. The firm operates four Asian-American supermarkets in Los Angeles and seeks to expand.
What type of business is Maison Solutions Class A Common Stock?
Maison Solutions Inc., together with its subsidiaries, operates as a specialty grocery retailer in the United States. The company offers perishable products, such as meat, seafood, vegetables, and fruit; non-perishable products, including grocery products comprising cooking utensils, canned foods, Chinese and Asian seasonings and spices, and snacks, as well as liquor, cigarette, lottery, newspaper, reusable bag, non-food, and health products; and general merchandise, beauty care, pharmacy, fuel, and other items and services in its stores. It also offers its products online. The company was formerly known as Maison International, Inc. and changed its name to Maison Solutions Inc. in September 2021. Maison Solutions Inc. was incorporated in 2019 and is headquartered in Monterey Park, California.
What sector is Maison Solutions Class A Common Stock in?
Maison Solutions Class A Common Stock is in the Consumer Defensive sector
What industry is Maison Solutions Class A Common Stock in?
Maison Solutions Class A Common Stock is in the Grocery Stores industry
What country is Maison Solutions Class A Common Stock from?
Maison Solutions Class A Common Stock is headquartered in United States
What is Maison Solutions Class A Common Stock website?
https://maisonsolutionsinc.com
Is Maison Solutions Class A Common Stock in the S&P 500?
No, Maison Solutions Class A Common Stock is not included in the S&P 500 index
Is Maison Solutions Class A Common Stock in the NASDAQ 100?
No, Maison Solutions Class A Common Stock is not included in the NASDAQ 100 index
Is Maison Solutions Class A Common Stock in the Dow Jones?
No, Maison Solutions Class A Common Stock is not included in the Dow Jones index
When was Maison Solutions Class A Common Stock the previous earnings report?
No data
When does Maison Solutions Class A Common Stock earnings report?
Next earnings report date is not announced yet